Dahong Zhang

Mr. Dahong Zhang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
BZBin Zheng
Bin Zheng
DLDingyi Liu
Dingyi Liu
XQXiaowen Qin
Xiaowen Qin
DZDahong Zhang
Dahong Zhang
DZDahong Zhang
Dahong Zhang
Mucosal tissue acts as a barrier between the human body’s internal environment and the external world. The mucosal tissue is shielded from injurious environmental chemicals, toxins, and pathogens by a mucus layer lining above the mucosal tissue, and meanwhile the periodic mucosal clearance accelerates the removal of mucoadhesive components. And therefore, transmucosal drug delivery is limited. Nanocarriers for mucosal drug delivery is recently developed to enhance either long retention of drugs within the mucus layer or rapid translocation of drugs across the mucus layer. Among all these types of drug delivery systems, mucoadhesive-to-mucopenetrating nanocarriers transport drugs most efficiently into targeted mucosal tissues. In this review, recent progress on the mucoadhesive-to-mucopenetrating drug delivery systems and their application are updated.

3 August 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
FXFeiya Xu
Feiya Xu
YZYiming Zhao
Yiming Zhao
MHMin Hu
Min Hu
DZDahong Zhang
Dahong Zhang
NKNing Kong
Ning Kong
Seok Ki ChoiSeok Ki Choi
Seok Ki Choi
We report a novel lanthanide-doped core–shell nanostructure NaYF 4 :Yb,Er@NaGdF 4 :Nd@SiO 2 -RB with a unique design feature that integrates luminescence imaging in biological window II, magnetic resonance imaging, and NIR-excited photodynamic antimicrobial chemotherapy, in a single nanoscale entity.

30 October 2022 in Drug Delivery
Verified
Journal Article
Open access
YMYixuan Mou
Yixuan Mou
DZDahong Zhang
Dahong Zhang
WLWing-Fu Lai
Wing-Fu Lai
DZDahong Zhang
Dahong Zhang
Cancer has long been a hot research topic, and recent years have witnessed the incidence of cancer trending toward younger individuals with great socioeconomic burden. Even with surgery, therapeutic agents serve as the mainstay to combat cancer in the clinic. Intensive research on nanomaterials can overcome the shortcomings of conventional drug delivery approaches, such as the lack of selectivity for targeted regions, poor stability against degradation, and uncontrolled drug release behavior. Over the years, different types of drug carriers have been developed for cancer therapy. One of these is liposome-in-gel (LP–Gel), which has combined the merits of both liposomes and hydrogels, and has emerged as a versatile carrier for cancer therapy. LP–Gel hybrids have addressed the lack of stability of conventional liposomes against pH and ionic strength while displaying higher efficiency of delivery hydrophilic drugs as compared to conventional gels. They can be classified into three types according to their assembled structure, are characterized by their nontoxicity, biodegradability, and flexibility for clinical use, and can be mainly categorized based on their controlled release, transmucosal delivery, and transdermal delivery properties for anticancer therapy. This review covers the recent progress on the applications of LP–Gel hybrids for anticancer therapy.

4 January 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
DZDahong Zhang
Dahong Zhang
GWGuoqing Wu
Guoqing Wu
DZDahong Zhang
Dahong Zhang
WLWing-Fu Lai
Wing-Fu Lai

6 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YCYao cenchao
Yao cenchao
DZDahong Zhang
Dahong Zhang
HWHeng Wang
Heng Wang
PZPu Zhang
Pu Zhang
Recent studies have revealed the functional roles of cell membrane coated-nanoparticles (CMNPs) in tackling urological diseases, including cancers, inflammation, and acute kidney injury. Cells are a fundamental part of pathology to regulate nearly all urological diseases, and, therefore, naturally derived cell membranes inherit the functional role to enhance the biopharmaceutical performance of their encapsulated nanoparticles on drug delivery. In this review, methods for CMNP synthesis and surface engineering are summarized. The application of different types of CMNPs for tackling urological diseases is updated, including cancer cell membrane, stem cell membrane, immune cell membrane, erythrocytes cell membranes, and extracellular vesicles, and their potential for clinical use is discussed.

25 October 2024 in Drug Delivery
Verified
Journal Article
Open access
HLHaichang Li
Haichang Li
ZLZhenghong Liu
Zhenghong Liu
DZDahong Zhang
Dahong Zhang
DZDahong Zhang
Dahong Zhang
Hydrogels, comprising 3D hydrophilic polymer networks, have emerged as promising biomaterial candidates for emulating the structure of biological tissues and delivering drugs through topical administration with good biocompatibility. Nanozymes can catalyze endogenous biomolecules, thereby initiating or inhibiting in vivo biological processes. A nanozyme-hydrogel composite inherits the biological functions of hydrogels and nanozymes, where the nanozyme serves as the catalytic core and the hydrogel forms the structural scaffold. Moreover, the composite can concentrate nanozymes in targeted lesions and catalyze the binding of a specific group of substrates, resulting in pathological microenvironment remodeling and drug-penetrating barrier impairment. The composite also shields nanozymes to prevent burst release during catalytic production and reduce related toxicity. Currently, the application of these composites has been extended to antibacterial, anti-inflammatory, anticancer, and tissue repair applications. In this review, we elucidate the preparation methods for nanozyme-hydrogel composites, provide compelling evidence of their advantages in drug delivery and provide a comprehensive overview of their biological application.